M. Parry
发表
Kristofer C. Berrett,
Albright,
N. Camp,
2019
.
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.
N. Camp,
L. Cannon-Albright,
A. Cox,
2016,
Cancer research.
N. Camp,
L. Cannon-Albright,
A. Cox,
2016
.
Crispin J. Miller,
N. Clarke,
N. Dhomen,
2019,
European urology oncology.
Crispin J. Miller,
N. Clarke,
N. Dhomen,
2018
.
R. Marais,
C. Dive,
F. Blackhall,
2017,
Molecular oncology.
A. Freeman,
M. Emberton,
H. Whitaker,
2020,
BJU international.
D. Berney,
M. Parmar,
M. Sydes,
2022,
Genome medicine.
P. Cremaschi,
G. Attard,
S. Friedrich,
2022,
bioRxiv.
D. Oscier,
Z. Davis,
M. Rose-Zerilli,
2018,
Blood advances.
Parker,
D. Oscier,
M. Rose-Zerilli,
2015
.
J. Mayerle,
M. Lerch,
J. Schnekenburger,
2002,
The Journal of Biological Chemistry.
F. Schmitz,
J. Schnekenburger,
W. Domschke,
2008,
Journal of Medical Genetics.
J. Proudfoot,
D. Berney,
M. Parmar,
2023,
Research square.
M. Parmar,
M. Sydes,
R. Eeles,
2020,
JCO precision oncology.
A. Freeman,
M. Emberton,
H. Whitaker,
2020,
European urology open science.
D. Oscier,
Z. Davis,
S. Ennis,
2013,
PloS one.
K. Stamatopoulos,
R. Rosenquist,
D. Oscier,
2015,
Clinical Cancer Research.
K. Stamatopoulos,
D. Oscier,
J. Strefford,
2015,
Leukemia & lymphoma.
Ryan Abo,
Stacey Knight,
Angela Cox,
2011,
Cancer Epidemiology, Biomarkers & Prevention.
A. Freeman,
C. Moore,
M. Emberton,
2020,
European urology.
A. Freeman,
M. Emberton,
H. Whitaker,
2020,
BMJ Open.
D. Oscier,
N. Cross,
M. Rose-Zerilli,
2015,
Haematologica.
J. Proudfoot,
D. Berney,
M. Parmar,
2023,
Research square.
M. Parmar,
M. Sydes,
N. James,
2019,
Journal of Clinical Oncology.
A. Tutt,
C. Caldas,
E. Provenzano,
2023,
Nature communications.
K. Stamatopoulos,
R. Rosenquist,
D. Oscier,
2014
.
Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus.
Kristofer C. Berrett,
N. Camp,
L. Cannon-Albright,
2016,
Cancer research.